Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Tobin

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Genetics and Cytogenetics|August 25, 2004
Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemiaAnna Ferrer, Juha Ollila, Gerard Tobin, et al.
Blood|March 5, 2005
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation statusPawel Grabowski, Magnus Hultdin, Karin Karlsson, et al.
European Journal of Haematology|February 28, 2009
In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosisElin Lindhagen, Maria Norberg, Meena Kanduri, et al.
Leukemia & Lymphoma|December 5, 2008
Rapamycin shows anticancer activity in primary chronic lymphocytic leukemia cells in vitro, as single agent and in drug combinationAnna Aleskog, Maria Norberg, Peter Nygren, et al.
Lancet (London, England)|December 21, 2002
Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemiaUlf Thunberg, Gerard Tobin, Anna Johnson, et al.
European Journal of Haematology|November 4, 2004
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemiaAnna Aleskog, Gerard Tobin, Anna Laurell, et al.
Blood|March 6, 2002
Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemiaGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
Blood|February 15, 2003
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitopeGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
Haematologica|April 12, 2005
Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcomeGerard Tobin, Ulf Thunberg, Anna Laurell, et al.
BMC Cancer|July 31, 2012
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myelomaLina Y Dimberg, Anna Dimberg, Karolina Ivarsson, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Genetics and Cytogenetics|August 25, 2004
Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemiaAnna Ferrer, Juha Ollila, Gerard Tobin, et al.
Blood|March 5, 2005
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation statusPawel Grabowski, Magnus Hultdin, Karin Karlsson, et al.
European Journal of Haematology|February 28, 2009
In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosisElin Lindhagen, Maria Norberg, Meena Kanduri, et al.
Leukemia & Lymphoma|December 5, 2008
Rapamycin shows anticancer activity in primary chronic lymphocytic leukemia cells in vitro, as single agent and in drug combinationAnna Aleskog, Maria Norberg, Peter Nygren, et al.
Lancet (London, England)|December 21, 2002
Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemiaUlf Thunberg, Gerard Tobin, Anna Johnson, et al.
European Journal of Haematology|November 4, 2004
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemiaAnna Aleskog, Gerard Tobin, Anna Laurell, et al.
Blood|March 6, 2002
Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemiaGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
Blood|February 15, 2003
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitopeGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
Haematologica|April 12, 2005
Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcomeGerard Tobin, Ulf Thunberg, Anna Laurell, et al.
BMC Cancer|July 31, 2012
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myelomaLina Y Dimberg, Anna Dimberg, Karolina Ivarsson, et al.
Pageof 4